Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

Karl G. Braslis, Richard C. David, Eustos Nelson, Francisco Civantos, Mark S. Soloway

Research output: Contribution to journalArticle

25 Scopus citations


We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

Original languageEnglish
Pages (from-to)329-331
Number of pages3
Issue number2
StatePublished - Jan 1 1995


ASJC Scopus subject areas

  • Urology

Cite this